<unk> (injection) is a synthetically manufactured analog of calcitriol that is FDA approved for the treatment of secondary hyperparathyroidism associated with chronic kidney disease Stage 5.   Common adverse reactions include edema, hypertension, diarrhea, nausea, vomiting, dizziness, headache.
Paricalcitol 
Sorbitol 
Sorbitol
Tacalcitol
Mitobronitol
Miglitol
Mannitol
Lisuride